VA agrees to reimburse activity-tracking device

The Department of Veterans Affairs has approved the StepWatch activity-tracking device and Orthocare Innovation's Europa for reimbursement under the agency's National Orthotic and Prosthetic Program. "We applaud VHA's efforts to lead the field by being the first to systematically collect functional data to help gain improved insight into the performance of veterans who utilize lower limb prosthetics. With StepWatch identified as the only activity tracker among a very crowded field that meets its requirements, Modus Health is committed to supporting veterans in the use of our technology to help improve the quality of its clinical care," said Modus Health CEO Doug McCormack. Release

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.